CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway

被引:48
作者
Tang, Ming-Rui [1 ]
Wang, Yu-Xin [1 ]
Guo, Shu [1 ]
Han, Si-Yuan [1 ]
Wang, Di [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Plast Surg, Shenyang 110001, Peoples R China
关键词
Melanoma; CSMD1; Apoptosis; Survival rate; Signaling pathway; GROWTH-FACTOR-BETA; PROSTATE CANCERS; DELETION; BREAST; OVEREXPRESSION; RECURRENCE; EXPRESSION; RESISTANCE; APOPTOSIS; SURVIVAL;
D O I
10.1007/s10495-012-0727-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we studied the effects of CUB and Sushi multiple domains 1 gene (CSMD1) expression in A375 melanoma cells in vivo and in vitro. CSDM1 expression decreased proliferation and migration, and increased apoptosis and G(1) arrest in A375 cells in vitro. Expression of CSDM1 in established xenografted tumors decreased tumor size and weight, and decreased the density of intratumor microvessels. The survival rate of mice with tumors expressing CSMD1 was significantly higher than mice with tumors that did not express CSDM1. These results confirm the role of CSDM1 as a tumor suppressor gene in melanoma cells. Furthermore, we found that CSMD1 can interact with Smad3, activate Smad1, Smad2, and Smad3, and increase the expression of Smad4. These results might prove helpful for the development of novel therapies for melanoma treatment.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
[1]  
Agarwala Sanjiv S., 1996, Current Opinion in Oncology, V8, P167, DOI 10.1097/00001622-199603000-00015
[2]  
ALESSANDRI G, 1987, CANCER RES, V47, P4243
[3]  
Anbazhagan R, 1998, AM J PATHOL, V152, P815
[4]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[5]  
Atkins MB, 2000, CANCER J SCI AM, V6, pS8
[6]   IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[7]   The melanoma epidemic:: Res ipsa loquitur [J].
Beddingfield, FC .
ONCOLOGIST, 2003, 8 (05) :459-465
[8]   Association of 8p23 deletions with poor survival in head and neck cancer [J].
Bockmühl, U ;
Ishwad, CS ;
Ferrell, RE ;
Gollin, SM .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 124 (04) :451-455
[9]   Malignant melanoma: genetics and therapeutics in the genomic era [J].
Chin, Lynda ;
Garraway, Levi A. ;
Fisher, David E. .
GENES & DEVELOPMENT, 2006, 20 (16) :2149-2182
[10]   The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes [J].
Diep, CB ;
Kleivi, K ;
Ribeiro, FR ;
Teixeira, MR ;
Lindgjaerde, OC ;
Lothe, RA .
GENES CHROMOSOMES & CANCER, 2006, 45 (01) :31-41